DJIA 17,798.49 0.00 0.00%
NASDAQ 5,127.53 0.00 0.00%
S&P 500 2,090.11 0.00 0.00%
market minute promo

Peregrine Pharmaceuticals (NASDAQ: PPHM)

1.30 -0.01 (-0.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PPHM $1.30 -0.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.30
Previous Close $1.31
Daily Range $1.28 - $1.32
52-Week Range $0.91 - $1.66
Market Cap $262.8M
P/E Ratio -4.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,027,682
Average Daily Volume 1,076,002
Current FY EPS -$0.34




Drug Makers

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website:

News & Commentary

Peregrine Pharmaceuticals' Stock Sank in September: Is It Now a Buy?

Peregrine Pharmaceuticals' stock had a rough September. Should investors take advantage of this pullback to add this speculative biopharma to their portfolios?

Another Double Digit Yield From A Debt-Free Company

Peregrine Pharmaceuticals (PPHM) Jumps: Stock Up 6.1%

Will Mallinckrodt (MNK) Surprise Earnings Again in Q4?

New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab's Enhanced Anti-Tumor Ac

New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab's Enhanced Anti-Tumor Activity When Combined With Checkpoint Inhibitors in Breast Cancer and Melanoma

Peregrine Pharmaceuticals 'The Art Of The Deal'

AstraZeneca's Diabetes Drug Gets CRL; Expands Cancer Deal

Lung Cancer Treatment Gets Personal

After years of languishing survival rate improvements in lung cancer, new personalized therapies yield hope of a dramatic boost in response rates and survival.

5 Things Peregrine Pharmaceuticals Wants You to Know

If you skipped Peregrine Pharmaceuticals' conference call, then you missed management discussing these five important events and strategies.

3 Small-Cap Biotech Stocks Crushing Shareholder Value With Stock Offerings

Issuing stock is way of life for some small-cap biotech companies looking to raise cash. However, these three in particular are notorious for diluting shareholder value.

See More PPHM News...

PPHM's Top Competitors

PPHM $1.30 (-0.76%)
Current stock: PPHM
AMGN $163.52 (0.00%)
Current stock: AMGN
GILD $108.00 (0.00%)
Current stock: GILD
BIIB $293.21 (0.00%)
Current stock: BIIB